Mercedes M. Monteleone
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
NeuO-mediated O-acetylation of uropathogenic Escherichia coli K1 capsule enhances resistance to phage and neutrophil killing.
Journal: Journal of bacteriology
Published: February 10, 2026
Cardiolipin inhibits the non-canonical inflammasome by preventing LPS binding to caspase-4/11.
Journal: The EMBO journal
Published: January 08, 2025
The septin modifier, forchlorfenuron, activates NLRP3 via a potassium-independent mitochondrial axis.
Journal: Cell chemical biology
Published: November 11, 2023
Quantifying Cell Death Induced by the NLRC4 Inflammasome.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 14, 2023
Fluorochrome-labeled inhibitors of caspase-1 require membrane permeabilization to efficiently access caspase-1 in macrophages.
Journal: European journal of immunology
Published: April 03, 2023
Measuring Non-canonical Inflammasome Activation in Neutrophils.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 25, 2022
Streptolysins are the primary inflammasome activators in macrophages during Streptococcus pyogenes infection.
Journal: Immunology and cell biology
Published: June 22, 2021
Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release.
Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release.
Journal: The Journal of experimental medicine
Published: July 09, 2020
The Salmonella pathogenicity island-2 subverts human NLRP3 and NLRC4 inflammasome responses.
Journal: Journal of leukocyte biology
Published: May 15, 2018
Interleukin-1β Maturation Triggers Its Relocation to the Plasma Membrane for Gasdermin-D-Dependent and -Independent Secretion.
Journal: Cell reports
Published: December 06, 2017
Last Updated: 09/26/2026